Literature DB >> 12823039

Development and validation of a molecular beacon probe-based real-time polymerase chain reaction assay for rapid detection of methicillin resistance in Staphylococcus aureus.

Sameer Elsayed1, Barbara L Chow, Nina L Hamilton, Daniel B Gregson, Johann D D Pitout, Deirdre L Church.   

Abstract

CONTEXT: A rapid, real-time, duplex, fluorescent molecular beacon probe-based polymerase chain reaction (PCR) assay was recently developed for the detection of methicillin-resistant Staphylococcus aureus.
OBJECTIVE: To describe the development and validation of this unique assay.
DESIGN: Prospective laboratory analysis.
SETTING: Urban health region/centralized diagnostic microbiology laboratory. BACTERIAL STRAINS: One hundred eighty-one previously characterized clinical and American Type Culture Collection isolates, including 50 strains each of methicillin-resistant and methicillin-sensitive S aureus, plus 50 strains of coagulase-negative staphylococci and 31 nonstaphylococcal isolates to ensure assay specificity. INTERVENTION: Assays were performed on purified genomic DNA extracted from growing bacterial colonies. Two sets of oligonucleotide primers were used to specifically amplify the mecA and nuc genes, followed by detection of amplicons using fluorophore-labeled molecular beacon probes. Assays were performed on the Mx4000 Multiplex Quantitative PCR System (Stratagene Inc, La Jolla, Calif). MAIN OUTCOME MEASURES: (1) Assay sensitivity and specificity, and (2) analytical sensitivity.
RESULTS: The assay demonstrated 100% sensitivity and 100% specificity, and accurately characterized isolates as methicillin-resistant S aureus, methicillin-sensitive S aureus, or methicillin-resistant coagulase-negative staphylococci, with test results available in 2.5 hours. The analytical sensitivity of the assay was determined to be between 6 and 60 genomic equivalents.
CONCLUSIONS: This assay is rapid, accurate, easy to perform, and is compatible with other real-time PCR instruments, making it a suitable alternative to conventional PCR methodologies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12823039     DOI: 10.5858/2003-127-845-DAVOAM

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

1.  Detection of methicillin-resistant Staphylococcus aureus directly from nasal swab specimens by a real-time PCR assay.

Authors:  David K Warren; Robert S Liao; Liana R Merz; Michael Eveland; W Michael Dunne
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

2.  Use of a multiplex molecular beacon platform for rapid detection of methicillin and vancomycin resistance in Staphylococcus aureus.

Authors:  Daniel Sinsimer; Surbhi Leekha; Steven Park; Salvatore A E Marras; Larry Koreen; Barbara Willey; Steve Naidich; Kimberlee A Musser; Barry N Kreiswirth
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Use of molecular beacon probes for real-time PCR detection of Plasmodium falciparum and other plasmodium species in peripheral blood specimens.

Authors:  Sameer Elsayed; Katherine Plewes; Deirdre Church; Barbara Chow; Kunyan Zhang
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

Review 4.  Molecular diagnostics of clinically important staphylococci.

Authors:  J Stepán; R Pantůcek; J Doskar
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

5.  Spectra MRSA, a new chromogenic agar medium to screen for methicillin-resistant Staphylococcus aureus.

Authors:  Jess F Peterson; Katherine M Riebe; Gerri S Hall; Deborah Wilson; Susan Whittier; Elizabeth Palavecino; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

6.  Comparison of the Roche LightCycler vanA/vanB detection assay and culture for detection of vancomycin-resistant enterococci from perianal swabs.

Authors:  L M Sloan; J R Uhl; E A Vetter; C D Schleck; W S Harmsen; J Manahan; R L Thompson; J E Rosenblatt; F R Cockerill
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.